Vecamyl Tablet
NDC Package 69413-558-40
Package Information
Vecamyl (mecamylamine hydrochloride) tablets is mecamylamine is used to treat moderately severe to severe high blood pressure. This formulation utilizes a tablet delivery system. Marketed by Vyera Pharmaceuticals, Llc, this product is identified by NDC 69413-558 and is authorized under FDA application ANDA204054.
Identification & Billing
- RxCUI: 1298874 - mecamylamine HCl 2.5 MG Oral Tablet
- RxCUI: 1298874 - mecamylamine hydrochloride 2.5 MG Oral Tablet
- RxCUI: 1373008 - vecamyl 2.5 MG Oral Tablet
- RxCUI: 1373008 - mecamylamine hydrochloride 2.5 MG Oral Tablet [Vecamyl]
- RxCUI: 1373008 - Vecamyl 2.5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69413 - Vyera Pharmaceuticals, Llc
- 69413-558 - Vecamyl
- 69413-558-40 - 100 TABLET in 1 BOTTLE
- 69413-558 - Vecamyl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69413-558-40 identifies a specific commercial package of 100 tablet in 1 bottle of Vecamyl, a human prescription drug labeled by Vyera Pharmaceuticals, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains mecamylamine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vyera Pharmaceuticals, Llc on March 19, 2013. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Mecamylamine is used to treat moderately severe to severe high blood pressure. It can also be used in sudden high blood pressure emergencies (malignant hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Mecamylamine belongs to a class of drugs known as ganglion blockers. It works by relaxing blood vessels so blood can flow more easily.
How is this Vyera Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69413055840. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.